Medisse, a Dutch biomaterial firm, has announced that it has raised €2.6m ($3.5m) in a series B round led by life science investor IIG with participation from existing backers Omnes Capital and University of Leiden-backed BioGeneration Ventures.
In addition to the €2.6m ($3.5m), Medisse will also receive an unspecified sum in the form of innovation credit from the Dutch Ministry of Economic Affairs.
The latest round of financing will be used by Medisse to further develop its lead product, an…
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
